Background: Storage temperature of bronchoalveolar lavage fluid (BALF) impacts cytological evaluation. The effect of storage temperature before bacterial culture has not been evaluated.
| INTRODUCTION
Bacterial pneumonia, characterized as inflammation of the lower airways and pulmonary parenchyma associated with bacterial infection, can result from primary or secondary pathogens. Considering that bacterial infection may be introduced through various routes and a wide variety of organisms can be involved, guidance of antimicrobial choices by culture and susceptibility testing is prudent. 1 Appropriate antimicrobial choice leads to an increased chance for a positive outcome. 2 Furthermore, airway sampling and culture allows for antibiotic deescalation, which decreases cost of treatment, drug-related adverse effects, and antimicrobial resistance selection pressure. 3 Multiple studies have concluded that antimicrobial treatment should be guided by bronchoalveolar lavage fluid (BALF) culture and susceptibility testing, if possible. [4] [5] [6] [7] A recent study evaluating bacterial culture and susceptibility in dogs with bacterial pneumonia showed that 26% of cases had at least 1 bacterial isolate that was resistant to empirically selected antimicrobials. 8 Considering the benefit of BALF culture and susceptibility, it is imperative that results accurately reflect present infections. Inappropriate sample handling could alter the reliability of BALF cultures, leading to inappropriate antimicrobial recommendations. Although the effects of BALF storage temperature on cytological evaluation have been described, studies assessing the effect of canine BALF storage temperature on bacterial culture have not been reported. 9, 10 Bordetella bronchiseptica and Escherichia coli are among the most common organisms isolated from BALF and transtracheal wash samples of dogs with lower airway disease, with prevalence ranging from 8 to 71.4% and 14.7 to 50.7%, respectively. 4, 5, 8, [11] [12] [13] Two or more bacterial species were isolated from 30.7 to 56% of samples. 4, 12 Individual bacterial species respond differently to environmental conditions, which raises concerns for bacterial interactions in culture. In urine specimens, Gram-negative bacilli such as E. coli have been shown to overgrow Gram-positive cocci. 14 Microbes in urine samples may grow or die off during storage at room temperature or shipping, resulting in inaccurate cultures. 15, 16 It is possible that airway samples behave similarly, but this possibility has not been evaluated in veterinary medicine.
Studies comparing immediate aerobic bacterial culture of canine BALF with storage for 24 hours at room temperature, refrigeration, and heat (simulating a sample inappropriately packaged for shipment) are lacking.
Our objectives were to evaluate the effect of BALF storage at various temperatures before aerobic bacterial culture. We hypothesized that storage at 25 and 37 C for 24 hours before culture would alter culture results.
| MATERIALS AND METHODS
This study was conducted as a prospective, controlled investigation. performed using a blind technique as previously described. 17 Briefly, a sterile 8-French ×42-inch plastic feeding tube (C. R. Bard Inc, Covington, Georgia) was passed through the sterile endotracheal tube and down the airway until gentle resistance was met. Two milliliters of sterile 0.9% saline per kilogram of body weight were instilled through the feeding tube. The dog's chest was coupaged as suction was applied to a sterile syringe attached to the feeding tube. If <50% of the infused sample fluid was recovered, a second aliquot of equal volume was instilled. If a second aliquot was used, the BALF from the 2 attempts was combined. Samples were capped to prevent contamination, labeled, and stored on ice until all samples were collected (maximum storage time of 15 minutes).
Each sample was gently mixed, and 500 μL of sample was centrifuged and subjected to Gram staining. Samples with positive Gram stains were excluded from the study. A 4 mL aliquot of BALF was removed from each sample. The remainder of the BALF from each dog was divided into 4 1-mL aliquots. These acted as controls and were reserved for culture as described below without further manipulation. The 4 mL aliquot was inoculated with B. bronchiseptica (wild-type obtained from a clinical patient) to achieve a final concentration of approximately 10 4 cfu/mL to simulate a primary bacterial pathogen. This cfu count was chosen based on a previous study that found a threshold concentration of 1.7 × 10 3 cfu/mL for defining clinically relevant bacterial growth. 18 Additionally, this aliquot was inoculated with E. coli (wild-type obtained from a clinical patient) to achieve a final concentration of approximately 1 × 10 2 cfu/mL to represent a contaminant bacterial strain. 18 The inoculated sample then was split into 4 1-mL aliquots, which were placed into each of 4 sterile tubes without additive.
One aliquot of the control BALF sample was immediately plated for aerobic bacterial culture (baseline). Of the 4 inoculated samples, 1 was plated immediately (baseline). One of each of the 3 remaining inoculated aliquots and the 3 remaining reserved aliquots were stored at 4, 25, or 37 C, respectively, for 24 hours, and then plated for aerobic bacterial culture. Temperatures during shipping can vary widely, and 37 C was chosen to simulate exposure to mid-summer temperatures in the southeastern United States. For plating, a .01 mL aliquot of BALF was inoculated onto blood agar and MacConkey agar using a calibrated loop. 19 Plates were incubated at 37 C for 18-24 hours on blood agar in 5% CO 2 and MacConkey agar in ambient air. Plates were examined and counts obtained for all organisms present. Organisms were identified by standard conventional methods. All bacterial cultures were incubated and examined in the same manner. 
| Statistical analysis

| RESULTS
The median age of the enrolled population was .78 years (range .68-.86).
No animal showed clinical signs suggestive of lower respiratory tract disease based on observation and physical examination. The BALF samples from all 8 dogs had negative Gram stains.
In all inoculated samples, colony counts for E. coli at baseline were less than the previously defined threshold concentration for defining clinically relevant bacterial growth. 20 For E. coli in inoculated samples ( Figure 1A ), a significant difference in growth was found as measured by cfu/mL among the various storage conditions (P < .001). Figure 1C ). One additional sample showed B. bronchiseptica growth after storage at 4 C, and 2 additional samples showed B. bronchiseptica growth after storage at 25 and 37 C. A significant difference was found among the various storage conditions (P = .003).
Escherichia coli grew in only 1 of 8 control samples ( Figure 1D ).
For this case, there was no E. coli growth at baseline, but after storage at 25 and 37 C growth was >1.7 × 10 3 cfu/mL (consistent with clinical relevance). For E. coli found in control samples, no statistically significant differences were found in cfu/mL between any combinations of storage conditions (P = .39).
No organisms other than B. bronchiseptica and E. coli were identified in any sample or after any storage condition.
| DISCUSSION
Aerobic bacterial culture results from BALF that had been refrigerated at 4 C for 24 hours before culture were representative of results from samples that were immediately cultured. This was true for both control and inoculated samples. Inoculated samples that were exposed to room temperature (25 C) or heat (37 C) for 24 hours showed overgrowth of contaminant E. coli. Control samples with zero or subclinical growth of B. bronchiseptica at baseline that were exposed to heat for 24 hours showed overgrowth of B. bronchiseptica, leading to growth that could be misinterpreted as a clinically relevant concentration (≥1.7 × 10 3 cfu/mL).
Samples inoculated with clinical concentrations of B. bronchiseptica
showed variable results after storage at 25 and 37 C, with some cfu con- Many practitioners must send BALF samples to external laboratories for culture. These samples may be held for courier pickup or shipped overnight. Anecdotally, it is common for these laboratories to receive samples that have not been packaged appropriately (eg, ice packs, etc), or that have been packaged with ice packs that have subsequently melted. This leaves the samples exposed to, at minimum, ambient temperatures. However, temperatures inside a vehicle can increase rapidly.
Over an ambient temperature range of 22 to 35 C, internal temperatures in a car increase an average of 23 C in just 1 hour. 21 Our study showed that exposure to both room temperature and heating could lead to false culture results. For this reason, proper packaging and sample handling in transit to a microbiological laboratory is imperative.
We used 1.7 × 10 3 cfu/mL as a distinction between clinically relevant and unimportant bacterial concentrations based on a previous study. 20 For analytical purposes, it was necessary to have a strict cutoff. Given the baseline culture results, it is apparent that these both were initially clinically relevant infections. It is possible that the recommended cutoff for clinical relevance should be different in samples that have been refrigerated before aerobic bacterial culture rather than immediately cultured.
We elected to use B. bronchiseptica and E. coli as representative bacterial agents in BALF samples. We chose these bacteria because of their high prevalence in lower airway disease as well as their variable biologic behavior. In recent studies, B. bronchiseptica has been among the most common bacterial isolates in BALF and transtracheal wash samples from dogs with lower airway disease, ranging from 8 to 71.4% prevalence. 4, 5, 8, [11] [12] [13] Likewise, E. coli is the most commonly isolated enterobacteriaceae, at between 14.7 and 50.7% prevalence. 4, 5, 8 As many as 30.7-56% of samples have ≥2 bacterial species isolated, although B. bronchiseptica was found to be the organism most commonly isolated in pure culture. 4, 12 Although E. coli may be present in the lower airways as a clinical infection, such as secondary to aspiration pneumonia, it also may be present in the lower airways of healthy dogs. A recent study showed the presence of bacteria from the family enterobacteriaceae in both nasal swabs and BALF of healthy dogs. 22 Another study found E. coli in the pharynx of clinically healthy dogs. 23 Thus, E. coli isolated from a BALF aerobic bacterial culture may be evi- Bordetella bronchiseptica may be isolated from asymptomatic infected animals, convalescent carriers, and transiently colonized animals. 26 Based on history and physical examination, a clinical infection with B. bronchiseptica was not suspected but neither BALF cytology nor thoracic imaging was performed for any patient in our study. We consider this omission to be a limitation of the study. All 3 of the control samples that grew B. bronchiseptica at baseline had a decrease in B. bronchiseptica growth after storage at 4 C. Isolation rates of Bordetella pertussis and Bordetella parapertussis, 2 organisms closely related to B. bronchiseptica, decrease when transport occurs at 4 C. 27 Bordetella bronchiseptica, like B. pertussis and B. parapertussis, is a mesophile, meaning that it grows best in moderate temperatures, typically 20 C-45 C, with the optimal temperature being 37 C. 28 At a temperature of 4 C, growth would be expected to be impaired.
A limitation of our study is that only 2 bacteria were assessed, and neither was assessed individually. Future studies are needed to evaluate if these results apply to other bacterial species. Additionally, only an aerobic bacterial culture was performed; no diagnostic tests to evaluate for mycoplasma were performed. Another limitation is that bacteria used for inoculation were in the exponential growth phase, which may not be the case in clinical patients. Only purposebred, male, Beagle dogs were used which is not representative of all clinical populations. Blinded BALF samples were used. Although the possibility of subclinical infection cannot be definitively ruled out, there were no indications to suggest that a clinical infection was present in any dog based on history and physical examination. Therefore, we believed that targeted sampling of a particular lung lobe (ie, using a bronchoscope) was not indicated.
In conclusion, aerobic bacterial cultures of BALF after storage for 24 hours at 4 C adequately represent samples that have been cultured immediately after sample procurement. Escherichia coli present in contaminant concentrations at baseline may grow to concentrations consistent with infection after storage at 25 or 37 C for 24 hours.
Bordetella bronchiseptica present in contaminant concentrations at baseline may grow to concentrations consistent with infection after storage at 37 C for 24 hours. Our findings indicate that BALF can be stored at 4 C for up to 24 hours before being submitted for aerobic bacterial culture.
